Printer Friendly

McGillin Promoted to Chief Commercial Officer at NeuroMetrix.

M2 PHARMA-November 10, 2016-McGillin Promoted to Chief Commercial Officer at NeuroMetrix

(C)2016 M2 COMMUNICATIONS

- US-based medical device company NeuroMetrix, Inc. (NASDAQ: NURO) has promoted Frank McGillin to senior vice president and chief commercial officer, the company said.

McGillin's most recent title was senior vice president and GM consumer.

In the expanded role, McGillin will have primary responsibility for sales, marketing, and business development for the company's Quell brand and wearable pain relief technology in both US and international markets.

Prior to joining NeuroMetrix, McGillin was at Philips Oral Healthcare and at Johnson and Johnson.

At Philips he was responsible for building the oral care business of Sonicare to become the #1 brand in the nearly USD 1bn dollar US power toothbrush market.

During his career he has launched over 50 new products and product upgrades and managed businesses in diagnostic imaging, healthcare informatics, medical devices, dental and consumer technology.

Quell is designed for people suffering from chronic pain. The wearable device is lightweight and can be worn during the day while active, and at night while sleeping.

It has been cleared by the FDA for treatment of chronic pain without a prescription. In a recent study, 81% of Quell users reported an improvement in their chronic pain.

Quell also offers advanced sleep tracking that provides feedback on eight dimensions of sleep including sleep duration, quality, body position, time out of bed, and repetitive leg movements throughout the night.

NeuroMetrix combines bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes.

The company's lead product is Quell, an over-the-counter wearable therapeutic device for chronic pain.

((Comments on this story may be sent to info@m2.com))

COPYRIGHT 2016 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2016 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 Pharma
Date:Nov 10, 2016
Words:282
Previous Article:Thermo Fisher Scientific, Hamilton Form Sample Storage Collaboration.
Next Article:Pacific West Medical to Distribute Paragonix SherpaPak Cardiac, Kidney Transport Systems.
Topics:

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters